Cravatex (Small Cap) Share Target 2024, 2025 To 2039
|
Cravatex Limited |
|||
|
Price: ₹453.75 | ||
| 52 Week Low: ₹351.00 52 Week High: ₹686.50 |
|||
| Market Capital: 109.54 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Cravatex Share Price Target For 2024
- 1.1.1: Cravatex Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Cravatex Share Price Target For 2025
- 1.2.1: Cravatex Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Cravatex Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Cravatex Financial Performance
- 3.0.1: Is Cravatex A Good Buy For Long Term?
To predict the Cravatex's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Cravatex Share Price Target For 2024
The line chart displays the monthly closing prices of Cravatex with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Cravatex shares in 2024, see the table below.
Cravatex Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 481.3 (+6.07%) | Price Action: 19 Dec 2024 Low |
| 2024 Target 2 | 476.32 (+4.97%) | Price Action: Oct 2011 High |
| 2024 Target 1 | 470.81 (+3.75%) | Price Action: Jun 2012 Low |
| Current Price | 453.75 | Cravatex's share price as of 23 Dec 2024 |
| Stop Loss 1 | 443.89 (-2.18%) | Price Action: Jan 2015 High |
| Stop Loss 2 | 439.0 (-3.26%) | Price Action: 09 Dec 2024 Low |
| Stop Loss 3 | 434.54 (-4.24%) | Price Action: 25 Nov 2024 High |
Short-Term Technical Outlook
Current Technical Position: Cravatex is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 50-day moving average at ₹447.16 serves as the nearest technical reference point.
Historical Returns: 3-month: -3.47% | 6-month: +12.78% | 1-year: -6.39%
Cravatex Share Price Target For 2025
The line chart displays the monthly closing prices of Cravatex with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Cravatex shares in 2025, see the table below.
Cravatex Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 695.25 (+53.22%) | Price Action: Chart |
| 2025 Target 2 | 682.29 (+50.36%) | Fibonacci Extension Level 100.00% |
| 2025 Target 1 | 670.15 (+47.69%) | Fibonacci Extension Level 64.90% |
| Current Price | 453.75 | Cravatex's share price as of 23 Dec 2024 |
| Stop Loss 1 | 401.28 (-11.57%) | Price Action: Apr 2022 High |
| Stop Loss 2 | 396.65 (-12.59%) | Price Action: Jul 2021 High |
| Stop Loss 3 | 392.34 (-13.54%) | Price Action: Nov 2017 Low |
Long-Term Technical Outlook
52-Week Range Analysis: Cravatex is currently trading at 30.6% of its 52-week range (₹351 - ₹686.5).
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -6.39% | 3-year: +14.68% | 5-year: +34.42%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Cravatex Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹453.75 | ||
| 2024 | ₹475.81 | +4.86% | ₹482.95 |
| 2025 | ₹465.57 | -2.15% | ₹478.25 |
| 2026 | ₹452.29 | -2.85% | ₹466.95 |
| 2027 | ₹439.75 | -2.77% | ₹455.66 |
| 2028 | ₹439.69 | -0.01% | ₹446.29 |
| 2029 | ₹430.94 | -1.99% | ₹437.40 |
| 2030 | ₹420.81 | -2.35% | ₹433.07 |
| 2031 | ₹407.96 | -3.05% | ₹421.77 |
| 2032 | ₹395.79 | -2.98% | ₹410.48 |
| 2033 | ₹394.84 | -0.24% | ₹400.76 |
| 2034 | ₹386.06 | -2.22% | ₹391.85 |
| 2035 | ₹376.06 | -2.59% | ₹387.89 |
| 2036 | ₹363.63 | -3.3% | ₹376.60 |
| 2037 | ₹351.82 | -3.24% | ₹365.30 |
| 2038 | ₹349.98 | -0.52% | ₹355.23 |
| 2039 | ₹340.39 | -2.74% | ₹345.60 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Cravatex Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 109.54 Crore | Market valuation of Cravatex's shares. |
| Revenue (TTM) | 202.63 Crore | Total revenue generated by Cravatex over the past twelve months. |
| Net Income (TTM) | +4.82 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +3.23% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +31.31% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-49.14% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
0.02 | Company's total debt divided by total shareholder equity. |
| Total Debt | 2.82 Crore | Sum of Cravatex's current & long-term financial obligations. |
| Total Cash | 23.58 Crore | Total amount of liquid funds available to Cravatex. |
Is Cravatex A Good Buy For Long Term?
Cravatex, a small-cap stock with a market capitalization of ₹109.54 crore, shows mixed signals for long-term investment. While its ₹202.63 crore revenue (TTM) and ₹4.82 crore net profit are positive, a significant -49.14% revenue drop in Q1 2024-25 raises concerns. The 23.58 crore cash balance against a 2.82 crore debt is encouraging. Past performance (53.13% return over three years) is attractive, but recent short-term returns are negative (-18.38% in the last three months, -15.41% YTD). Considering the volatility, Cravatex is an average buy for long-term investors with a high-risk tolerance. Further research is recommended.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
